These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 12411458

  • 21. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1679-89. PubMed ID: 15489104
    [Abstract] [Full Text] [Related]

  • 22. Endothelial cells overexpressing IL-8 receptor reduce cardiac remodeling and dysfunction following myocardial infarction.
    Zhao X, Zhang W, Xing D, Li P, Fu J, Gong K, Hage FG, Oparil S, Chen YF.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H590-8. PubMed ID: 23771691
    [Abstract] [Full Text] [Related]

  • 23. Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart.
    Trescher K, Bernecker O, Fellner B, Gyöngyösi M, Krieger S, Demartin R, Wolner E, Podesser BK.
    Eur J Cardiothorac Surg; 2004 Nov 15; 26(5):960-7. PubMed ID: 15519190
    [Abstract] [Full Text] [Related]

  • 24. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
    Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J.
    Cardiovasc Res; 2007 Jan 01; 73(1):130-42. PubMed ID: 17137568
    [Abstract] [Full Text] [Related]

  • 25. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats.
    Chao J, Zhang JJ, Lin KF, Chao L.
    Hum Gene Ther; 1998 Jan 01; 9(1):21-31. PubMed ID: 9458239
    [Abstract] [Full Text] [Related]

  • 26. Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.
    Okada H, Takemura G, Kosai K, Tsujimoto A, Esaki M, Takahashi T, Nagano S, Kanamori H, Miyata S, Li Y, Ohno T, Maruyama R, Ogino A, Li L, Nakagawa M, Nagashima K, Fujiwara T, Fujiwara H, Minatoguchi S.
    Am J Physiol Heart Circ Physiol; 2009 Mar 01; 296(3):H616-26. PubMed ID: 19151252
    [Abstract] [Full Text] [Related]

  • 27. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J.
    Circulation; 2008 Aug 19; 118(8):818-27. PubMed ID: 18678774
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of erythropoietin on cardiac remodeling after myocardial infarction.
    Nishiya D, Omura T, Shimada K, Matsumoto R, Kusuyama T, Enomoto S, Iwao H, Takeuchi K, Yoshikawa J, Yoshiyama M.
    J Pharmacol Sci; 2006 May 19; 101(1):31-9. PubMed ID: 16717399
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ginsenoside Re Preserves Cardiac Function and Ameliorates Left Ventricular Remodeling in a Rat Model of Myocardial Infarction.
    Yu Y, Sun J, Liu J, Wang P, Wang C.
    J Cardiovasc Pharmacol; 2020 Jan 19; 75(1):91-97. PubMed ID: 31599782
    [Abstract] [Full Text] [Related]

  • 34. Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats.
    Louhelainen M, Vahtola E, Forsten H, Merasto S, Kytö V, Finckenberg P, Leskinen H, Kaheinen P, Tikkanen I, Levijoki J, Mervaala E.
    J Hypertens; 2009 Oct 19; 27(10):2094-107. PubMed ID: 19730126
    [Abstract] [Full Text] [Related]

  • 35. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V, Bish LT, Pirolli TJ, Berry MF, Burdick J, Woo YJ.
    Ann Thorac Surg; 2004 Jun 19; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y, Ahmad N, Wani MA, Ashraf M.
    J Mol Cell Cardiol; 2004 Nov 19; 37(5):1041-52. PubMed ID: 15522281
    [Abstract] [Full Text] [Related]

  • 37. Kallikrein gene delivery attenuates hypertension and cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats.
    Yayama K, Wang C, Chao L, Chao J.
    Hypertension; 1998 May 19; 31(5):1104-10. PubMed ID: 9576121
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.